For the quarter ending 2026-03-31, UEEC had -$64,220 decrease in cash & cash equivalents over the period.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net (loss) | - | - | -2,132,440 | - |
| Net loss | - | 2,669,348 | - | - |
| Net (loss) | 1,531,004 | - | - | -1,846,846 |
| Stock for services and compensation | 0 | 0 | 0 | 1,120,125 |
| Write-off of inventory | - | 0 | 0 | 0 |
| (gain) loss on settlement of debt | - | 0 | - | - |
| Amortization expense | 1,013 | 1,013 | 1,012 | 2,025 |
| Amortization of right-of-use asset | -350 | -350 | -350 | -110 |
| Amortization of debt discount | 9,276 | 1,649 | - | - |
| Gain on settlement of debt | - | - | 0 | - |
| Inventory | - | 0 | - | - |
| (gain) loss on derivative liabilities | 22,404 | 28,334 | - | - |
| Prepaid and other current assets | 6,028 | 15,390 | 3,867 | -1,914 |
| Accounts payable and accrued expenses | 179,240 | -13,038 | 112,382 | 125,534 |
| Accrued liabilities - related party | 24,556 | 21,731 | 21,731 | 43,462 |
| Repayments of advance from related party | - | 145,000 | - | - |
| Accrued compensation | 46,200 | 16,500 | -20,471 | 95,238 |
| Proceeds from note payable - related party | - | 250,000 | - | - |
| Net cash used in operating activities | -84,339 | -553,127 | -175,157 | -458,658 |
| Proceeds from promissory note payable | - | 0 | - | - |
| Net cash used in investing activities | 0 | 0 | 0 | 0 |
| Proceeds from convertible notes payable | 0 | 350,000 | 130,000 | 290,000 |
| Payment of offering costs | - | 2,400 | - | - |
| Proceeds from sale of common stock | - | 0 | 65,708 | 0 |
| Repayment of advance from related party | - | - | 0 | 20,000 |
| Payment of offering costs | - | - | 2,400 | 0 |
| Advances from related party | 0 | 125,000 | 0 | 20,000 |
| Proceeds from note payable | 26,250 | - | 0 | - |
| Proceeds from sale of units | - | 0 | - | - |
| Repayments of note payable | 6,131 | - | - | - |
| Net cash provided by financing activities | 20,119 | 600,000 | 193,308 | 290,000 |
| Increase (decrease) in cash and cash equivalents | -64,220 | 46,873 | 18,151 | -168,658 |
| Cash and cash equivalents - beginning of period | 65,249 | 18,376 | 168,883 | - |
| Cash and cash equivalents - end of period | 1,029 | 65,249 | 18,376 | - |
United Health Products, Inc. (UEEC)
United Health Products, Inc. (UEEC)